$13.47
0.97% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US05463X1063
Symbol
AXGN

AxoGen, Inc. Target price 2024 - Analyst rating & recommendation

AxoGen, Inc. Classifications & Recommendation:

Buy
100%

AxoGen, Inc. Price Target

Target Price $17.57
Price $13.47
Potential
Number of Estimates 7
7 Analysts have issued a price target AxoGen, Inc. 2025 . The average AxoGen, Inc. target price is $17.57. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 7 Analysts recommend AxoGen, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the AxoGen, Inc. stock has an average upside potential 2025 of . Most analysts recommend the AxoGen, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 159.01 185.48
14.74% 16.65%
EBITDA Margin -10.01% 10.13%
44.20% 201.24%
Net Margin -14.11% -6.97%
35.58% 50.61%

7 Analysts have issued a sales forecast AxoGen, Inc. 2024 . The average AxoGen, Inc. sales estimate is

$185m
Unlock
. This is
2.56% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$186m 2.95%
Unlock
, the lowest is
$184m 1.74%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $159m 14.74%
2024
$185m 16.65%
Unlock
2025
$210m 12.97%
Unlock
2026
$236m 12.40%
Unlock
2027
$271m 15.23%
Unlock
2028
$304m 11.88%
Unlock

4 Analysts have issued an AxoGen, Inc. EBITDA forecast 2024. The average AxoGen, Inc. EBITDA estimate is

$18.8m
Unlock
. This is
2,708.82% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$23.3m 3,336.11%
Unlock
, the lowest is
$16.3m 2,368.61%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-15.9m 35.98%
2024
$18.8m 218.06%
Unlock
2025
$31.2m 66.08%
Unlock
2026
$42.4m 36.05%
Unlock
2027
$48.6m 14.51%
Unlock
2028
$54.7m 12.55%
Unlock

EBITDA Margin

2023 -10.01% 44.20%
2024
10.13% 201.24%
Unlock
2025
14.89% 46.99%
Unlock
2026
18.02% 21.02%
Unlock
2027
17.91% 0.61%
Unlock
2028
18.01% 0.56%
Unlock

5 AxoGen, Inc. Analysts have issued a net profit forecast 2024. The average AxoGen, Inc. net profit estimate is

$-12.9m
Unlock
. This is
10.88% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-12.3m 15.15%
Unlock
, the lowest is
$-13.6m 6.06%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-22.4m 26.09%
2024
$-12.9m 42.34%
Unlock
2025
$0.0 100.00%
Unlock
2027
$23.1m 75.00%
Unlock
2028
$34.5m 49.52%
Unlock

Net Margin

2023 -14.11% 35.58%
2024
-6.97% 50.61%
Unlock
2025
0.00% 100.00%
Unlock
2027
8.51% 51.96%
Unlock
2028
11.37% 33.61%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.51 -0.29
26.09% 43.14%
P/E negative
EV/Sales 3.40

5 Analysts have issued a AxoGen, Inc. forecast for earnings per share. The average AxoGen, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.29
Unlock
. This is
12.12% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.28 15.15%
Unlock
, the lowest is
$-0.31 6.06%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.51 26.09%
2024
$-0.29 43.14%
Unlock
2025
$0.00 100.00%
Unlock
2027
$0.53 76.67%
Unlock
2028
$0.79 49.06%
Unlock

P/E ratio

Current -40.79 273.19%
2024
-45.82 12.33%
Unlock
2027
25.66 42.85%
Unlock
2028
17.16 33.13%
Unlock

Based on analysts' sales estimates for 2024, the AxoGen, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.49 86.63%
2024
3.40 2.50%
Unlock
2025
3.01 11.48%
Unlock
2026
2.68 11.04%
Unlock
2027
2.33 13.22%
Unlock
2028
2.08 10.62%
Unlock

P/S ratio

Current 3.28 94.84%
2024
3.20 2.49%
Unlock
2025
2.83 11.48%
Unlock
2026
2.52 11.03%
Unlock
2027
2.18 13.22%
Unlock
2028
1.95 10.62%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today